Work by Davidson et al. [21] and Piskór et al. [22] also suggested the utility of determining MMP-7 levels or its expression in serum and cellular effusion in breast cancer as a diagnostic marker and as a differentiation marker from benign lesions [21,22]. Here, MMP7 is linked to breast cancer.